Circulating Levels of Renalase, Norepinephrine, and Dopamine in Dialysis Patients

REFERENCES

• Miller LM, Sood MM, Sood AR, Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Int Urol Nephrol. 2010;42:1007–1014.
   PubMedGoogle Scholar
• Paraskevas KI, Kotsikoris I, Koupidis SA, Tzovaras AA, Mikhailidis DP. Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. Int Urol Nephrol. 2010;42:999–1006.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Parlongo SG, Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354–1359.
   PubMed Web of Science ®Google Scholar
• Ritz E, Rump LC. Control of sympathetic activity–new insights; new therapeutic targets? Nephrol Dial Transplant. 2010;25:1048–1050.
   PubMedGoogle Scholar
• Yoshikawa M, Nakada T. High level of adrenal catecholamines in hypertensive subjects with impaired renal function. Int Urol Nephrol. 1986;18:185–192.
   PubMedGoogle Scholar
• Xu J, Li G, Wang P, Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005;115:1275–1280.
   PubMed Web of Science ®Google Scholar
• Desir GV, Tang L, Wang P, Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc. 2012; 1(4): e002634
   PubMed Web of Science ®Google Scholar
• Malyszko J, Zbroch E, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc. 2011;43:3004–3007.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Fan Z, He J, Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med. 2007;85:877–885.
   PubMed Web of Science ®Google Scholar
• Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One. 2010;5:e13496.
   PubMed Web of Science ®Google Scholar
• K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(Suppl 3):S1–S153.
   Google Scholar
• Massuo K, Lambert GW. Epinephrine and its role in the development of obesity and hypertension. Curr Hypertens Rev. 2011;7:144–152.
   Google Scholar
• Massuo K, Esler MD. Role of sympathetic nerve activity in obesity, hypertension and metabolic syndrome. Curr Hypertens Rev. 2010;6:83–91.
   Google Scholar
• Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG. Symapthetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens. 2002;20:3–9.
   PubMed Web of Science ®Google Scholar
• Domingos F, Escalda A. Causes of autonomic dysfunction in idiopathic recurrent kidney stone formers. Int Urol Nephrol. 2012;44:873–882.
   PubMedGoogle Scholar
• Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724–728.
   PubMed Web of Science ®Google Scholar
• Harris RC, Zhang MZ. Dopamine, the kidney, and hypertension. Curr Hypertens Rep. 2012;14:138–143.
   PubMed Web of Science ®Google Scholar
• Harris RC. Abnormalities in renal dopamine signaling and hypertension: the role of GRK4. Curr Opin Nephrol Hypertens. 2012;21:61–65.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Apparsundaram S, Lokhandwala MF. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther. 1991;256:486–491.
   PubMed Web of Science ®Google Scholar
• Hennebry SC, Eikelis N, Socratous F, Desir G, Lambert G, Schlaich M. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry. 2010;15:234–236.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu J, Velazquez H, Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011;79:853–860.
   PubMed Web of Science ®Google Scholar
• Eikelis N, Hennebry SC, Lambert GW, Schlaich MP. Does renalase degrade catecholamines? Kidney Int. 2011;79:1380.
   PubMedGoogle Scholar
• Gu R, Lu W, Xie J, Bai J, Xu B. Renalase deficiency in heart failure model of rats–a potential mechanism underlying circulating norepinephrine accumulation. PLoS One. 2011;6:e14633.
   PubMedGoogle Scholar
• Pandini V, Ciriello F, Tedeschi G, Rossoni G, Zanetti G, Aliverti A. Synthesis of human renalase1 in Escherichia coli and its purification as a FAD-containing holoprotein. Protein Expr Purif. 2010;72:244–253.
   PubMed Web of Science ®Google Scholar
• Baroni S, Milani M, Pandini V, Pavesi G, Horner D, Aliverti A. Is renalase a novel player in catecholaminergic signaling? The mystery of the catalytic activity of an intriguing new flavoenzyme. Curr Pharm Des. 2012 Oct 31. [ Epub ahead of print].
   Google Scholar
• Wang F, Wang N, Xing T, Cao Y, Xiang H. The cloning and expression of renalase and the preparation of its monoclonal antibody. J Shanghai Jiaotong Univ (Sci). 2009;14:376–379.
   Google Scholar
• Malyszko J, Zbroch E, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc. 2011;43:3004–3007.
   PubMed Web of Science ®Google Scholar
• Przybylowski P, Malyszko J, Kozlowska S, Malyszko J, Koc-Zorawska E, Mysliwiec M. Serum renalase, depends on kidney function but not on blood pressure in heart transplant recipients. Transplant Proc. 2011;43:3888–3891.
   PubMed Web of Science ®Google Scholar
• Boomsma F, Tipton KF. Renalase, a catecholamine-metabolising enzyme? J Neural Transm. 2007;114:775–776.
   PubMed Web of Science ®Google Scholar
• Badve SV, Roberts MA, Hawley CM, Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:1152–1161.
   PubMed Web of Science ®Google Scholar
• Kitchlu A, Clemens K, Gomes T, Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada. Nephrol Dial Transplant. 2012;27:1591–1598.
   PubMed Web of Science ®Google Scholar
• Malyszko J, Malyszko JS, Rysz J, Renalase, hypertension, and kidney – the discussion continues. Angiology. 2012 Sep 11. [ Epub ahead of print].
   Google Scholar